CITIUS PHARMACEUTICALS INC's ticker is CTXR and the CUSIP is 17322U207. A total of 77 filers reported holding CITIUS PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.28 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,195,920 | +1490.1% | 2,048,860 | +3169.0% | 0.00% | – |
| Q2 2023 | $75,210 | +21026.4% | 62,675 | -79.4% | 0.00% | – |
| Q1 2023 | $356 | -18.2% | 304,482 | -44.8% | 0.00% | – |
| Q4 2022 | $435 | -100.0% | 551,126 | -29.8% | 0.00% | -100.0% |
| Q3 2022 | $950,000 | -40.7% | 784,780 | -54.9% | 0.00% | 0.0% |
| Q2 2022 | $1,601,000 | +435.5% | 1,740,220 | +935.1% | 0.00% | – |
| Q1 2021 | $299,000 | +2890.0% | 168,128 | +1573.4% | 0.00% | – |
| Q4 2020 | $10,000 | -84.1% | 10,047 | -49.7% | 0.00% | – |
| Q3 2017 | $63,000 | – | 19,983 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHELSEA COUNSEL CO | 81,300 | $97,560 | 0.05% |
| Inspire Advisors, LLC | 198,472 | $238,166 | 0.05% |
| GSA CAPITAL PARTNERS LLP | 374,100 | $449 | 0.04% |
| FNY Investment Advisers, LLC | 15,000 | $18 | 0.02% |
| Horst & Graben Wealth Management LLC | 75,722 | $91,000 | 0.02% |
| PERRITT CAPITAL MANAGEMENT INC | 25,000 | $30,000 | 0.02% |
| Miller Investment Management, LP | 50,000 | $60,000 | 0.01% |
| MEITAV INVESTMENT HOUSE LTD | 13,040 | $603,622 | 0.01% |
| Pasadena Private Wealth, LLC | 10,965 | $13,158 | 0.00% |
| Virtu Financial LLC | 23,846 | $29 | 0.00% |